PRIMO 2022 | Redefining survivorship in oncology

Don Dizon, FACP, FASCO, MD, Brown University, Providence, RI, comments on the usage of the term survivorship in the field of supportive oncology, where it should be expanded to patients at the point of diagnosis and not just patients after treatment. Patients who have advanced or metastatic disease should additionally be taken into account as survival outcomes improve, and Prof. Dizon also emphasizes the need to incorporate survivorship in palliative care, as patient concerns regarding fertility should be taken into consideration. This interview took place at the 7th Annual Practical Recommendations in Immuno and Molecular Oncology Meeting (PRIMO 2022).